Infant Bacterial Therapeutics
Pre-clinicalInfant Bacterial Therapeutics develops pharmaceutical products to prevent and treat diseases in infants by modulating the infant gut microbiome.
Founded
2014
Focus
BiologicsMicrobiome
About
Infant Bacterial Therapeutics develops pharmaceutical products to prevent and treat diseases in infants by modulating the infant gut microbiome.
Funding History
3Total raised: $30M
IPOUndisclosedUndisclosedJun 15, 2021
Series B$20MUndisclosedMar 15, 2020
Series A$10MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2014
LocationStockholm, Sweden
StagePre-clinical
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile